Roivant Sciences Ltd. (ROIV)
26.46
-0.29
(-1.08%)
USD |
NASDAQ |
Feb 13, 10:45
Roivant Sciences EPS Diluted (Quarterly) : -0.3816 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Immunovant, Inc. | -0.6095 |
| GSK Plc | 0.414 |
| Kiniksa Pharmaceuticals International Plc | 0.2303 |
| Silence Therapeutics Plc | -0.1479 |
| Adaptimmune Therapeutics Plc | -0.1163 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -313.70M |
| Revenue (Quarterly) | 1.999M |
| Total Expenses (Quarterly) | 267.89M |
| Enterprise Value | 15.43B |
| Gross Profit Margin (Quarterly) | 30.42% |
| Profit Margin (Quarterly) | -15.69K% |
| Earnings Yield | -4.42% |
| Normalized Earnings Yield | -4.841 |